Decheng Capital

Decheng Capital

Decheng Capital is a venture capital company founded in 2011.

Decheng Capital is a venture capital firm that provides capital to early and growth stage life science companies in China. They are a team of investment professionals with complementary expertise, a long history of working together and a shared dedication to building successful companies that span the full spectrum of the life sciences industry. Their domain knowledge, access to innovative technologies and ability to bring proven Western products to China make them the preferred partner for entrepreneurs, domestic and multinational companies, government agencies and investors.

Decheng Capital is located in Shanghai and Silicon Valley and founded in 2012. With over $1 billion in capital under management, Decheng is poised to deliver returns for our investors and create value for our entrepreneur partners.

Investment

Decheng Capital's investments include Mynosys Cellular Devices, Hummingbird Bioscience, AnHeart Therapeutics, Baoyuan Biomedical, Bioheng, Luckin Coffee, Terns Pharmaceuticals, Polares Medical and Mindstrong Health.

Their exited investments include Invitae, Luckin Coffee, Arcus Biosciences, ARMO BioSciences, GeneWEAVE and SentreHEART.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
Sema4 (Mount Sinai Genomics, Inc.)

Mount Sinai Genomics is a Connecticut-based medical genetics practice at the Mount Sinai Health System.

Mammoth Biosciences is an American company based in San Francisco founded on June 1, 2017. Mammoth Biosciences uses CRISPR technology to develop bio-sensing technologies for diagnostics in industries such as healthcare, agriculture, manufacturing, and forensics.

Cue Health is a San Diego-based medical device company working to track health information at the molecular level.

Mammoth Diagnostics is a Brisbane, California-based company founded by Jennifer Doudna, Ashley Tehranchi, Trevor Martin, Janice Chen and Lucas Harrington.

A biopharmaceutical company developing antibodies for cancer, inflammatory diseases and ophthalmic diseases

GeneWEAVE is a manufacturer and supplier of clinical diagnostic solutions.

ReadCoor is a Cambridge, Massachusetts-based company.

Armo Bio Sciences is a Redwood City, California-based company.

14 Results
Results per page:
Page 1 of 1

Associated investment funds

Investment Fund
Total offering (USD)
Total sold (USD)
Location
Date signed
Decheng Capital China Life Sciences USD Fund III, L.P.
450,000,000
April 30, 2018
3 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Aaron Li, MBA

Associate

Clair Chin, M.D., MBA

Associate

Dan Zabrowski, Ph.D.

Venture Partner

Katherine Xu, Ph.D.

Partner

Min Cui, Ph.D.

Managing Director

Nick Pliam, M.D., Ph.D.

Partner

Peter Colabuono

Principal

Qiang Xu, Ph.D.

Partner

Tony Tong, Ph.D.

Principal

Victor E. Tong, Jr.

Partner

Wei Xu

Partner

Yang Lu, MBA

Associate

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.